Kentucky Risperdal Claim Settled for $15.5M

 

On December 22, 2015, Janssen Pharmaceuticals and its parent company, Johnson & Johnson, entered into a settlement with the Commonwealth of Kentucky, agreeing to pay $15.5 million to the state, sufficiently disclose the associated risks of the drug, and cease the company’s promotion of Risperdal for non-FDA approved uses. Read more »

 

No-Obligation Free Consultation

Contact us by phone at (618) 656-4400 or email us below.


 

Your information will be used only so that we may contact you to evaluate your case. Your contact information will never be shared or sold to anyone other than TorHoerman Law.